Efficacy and Safety of Ceritinib (450 mg/d or 600 mg/d) With Food Versus 750-mg/d Fasted in Patients With ALK Receptor Tyrosine Kinase (ALK)–Positive NSCLC: Primary Efficacy Results From the ASCEND-8 Study

Autor: Cho, Byoung Chul, Obermannova, Radka, Bearz, Alessandra, McKeage, Mark, Kim, Dong-Wang, Batra, Ullas, Borra, Gloria, Orlov, Sergey, Kim, Sang-We, Geater, Sarayut L., Postmus, Pieter E., Laurie, Scott A., Park, Keunchil, Yang, Cheng-Ta, Ardizzoni, Andrea, Bettini, Anna C., de Castro, Gilberto, Jr., Kiertsman, Flavia, Chen, Zhe, Lau, Yvonne Y., Viraswami-Appanna, Kalyanee, Passos, Vanessa Q., Dziadziuszko, Rafal
Zdroj: In Journal of Thoracic Oncology July 2019 14(7):1255-1265
Databáze: ScienceDirect